Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 10,298 shares at $19.14 ($197K) on 2025-07-28, disclosed to the SEC on 2025-07-30.
Open-market sale of $197k URGN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.14 | 5,149 | $99K | 50.0% |
| 2 | $19.14 | 5,149 | $99K | 50.0% |
| Total | $19.14 avg | 10,298 | $197K | 100% |
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |